136 related articles for article (PubMed ID: 30539740)
1. Relationship between amikacin blood concentration and ototoxicity in low birth weight infants.
Endo A; Nemoto A; Hanawa K; Maebayashi Y; Hasebe Y; Kobayashi M; Naito A; Kobayashi Y; Yamamoto S; Isobe K
J Infect Chemother; 2019 Jan; 25(1):17-21. PubMed ID: 30539740
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of nephrotoxicity and ototoxicity following amikacin administration once daily or every 48 hours in neonates.
Endo A; Hanawa K; Nemoto A; Ishikawa T; Kazama S; Kagami Y; Maebayashi Y; Katsumata N; Naito A; Kobayashi Y; Kawano Y; Hanawa T
Medicine (Baltimore); 2022 Oct; 101(43):e31425. PubMed ID: 36316882
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring of amikacin in preterm and term infants.
Siddiqi A; Khan DA; Khan FA; Razzaq A
Singapore Med J; 2009 May; 50(5):486-9. PubMed ID: 19495517
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring of amikacin in septic patients.
Duszynska W; Taccone FS; Hurkacz M; Kowalska-Krochmal B; Wiela-Hojeńska A; Kübler A
Crit Care; 2013 Jul; 17(4):R165. PubMed ID: 23886243
[TBL] [Abstract][Full Text] [Related]
6. Prospective Evaluation of a Model-Based Dosing Regimen for Amikacin in Preterm and Term Neonates in Clinical Practice.
Smits A; De Cock RF; Allegaert K; Vanhaesebrouck S; Danhof M; Knibbe CA
Antimicrob Agents Chemother; 2015 Oct; 59(10):6344-51. PubMed ID: 26248375
[TBL] [Abstract][Full Text] [Related]
7. Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review.
Jenkins A; Thomson AH; Brown NM; Semple Y; Sluman C; MacGowan A; Lovering AM; Wiffen PJ;
J Antimicrob Chemother; 2016 Oct; 71(10):2754-9. PubMed ID: 27494904
[TBL] [Abstract][Full Text] [Related]
8. Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study.
Bhatt-Mehta V; Schumacher RE; Faix RG; Leady M; Brenner T
Pediatrics; 1999 Apr; 103(4):e48. PubMed ID: 10103340
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series.
Namkoong H; Morimoto K; Nishimura T; Tanaka H; Sugiura H; Yamada Y; Kurosaki A; Asakura T; Suzuki S; Fujiwara H; Yagi K; Ishii M; Tasaka S; Betsuyaku T; Hoshino Y; Kurashima A; Hasegawa N
BMC Infect Dis; 2016 Aug; 16():396. PubMed ID: 27506679
[TBL] [Abstract][Full Text] [Related]
10. [Optimalisation of netilmicin dosage based on therapeutic drug monitoring during the first days of life in very preterm neonates (gestational age 23-32 weeks)].
Rutkowska M; Kamińska E; Piekarczyk A; Nowicka K; Polak K; Nowakowska-Szyrwińska E; Szamotulska K
Med Wieku Rozwoj; 2009; 13(4):252-9. PubMed ID: 20081273
[TBL] [Abstract][Full Text] [Related]
11. Once-daily dosing of amikacin for treatment of
Lee H; Sohn YM; Ko JY; Lee SY; Jhun BW; Park HY; Jeon K; Kim DH; Kim SY; Choi JE; Moon IJ; Shin SJ; Park HJ; Koh WJ
Int J Tuberc Lung Dis; 2017 Jul; 21(7):818-824. PubMed ID: 28633708
[TBL] [Abstract][Full Text] [Related]
12. [In the search for effective and safe dose of amikacin in patients with chronic kidney disease].
Gomółka M; Szamotulska K; Rymarz A; Brodowska-Kania D; Dubchak I; Piechota W; Jurkiewicz D; Niemczyk S
Pol Merkur Lekarski; 2014 Apr; 36(214):240-4. PubMed ID: 24868895
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an amikacin loading dose for nosocomial infections in very low birthweight infants.
Berger A; Kretzer V; Gludovatz P; Heinze G; Haiden N; Pollak A
Acta Paediatr; 2004 Mar; 93(3):356-60. PubMed ID: 15124839
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of pentoxifylline on amikacin-induced ototoxicity.
El-Anwar MW; Abdelmonem S; Nada E; Galhoom D; Abdelsameea AA
Ear Nose Throat J; 2018 Aug; 97(8):E8-E12. PubMed ID: 30138519
[TBL] [Abstract][Full Text] [Related]
15. [Experimental and clinical studies of intravenous infusion of amikacin in acute respiratory tract infections].
Ito T
Jpn J Antibiot; 1982 Aug; 35(8):2111-25. PubMed ID: 7154253
[TBL] [Abstract][Full Text] [Related]
16. Amikacin dosing in neonates: evaluation of a dosing chart based on population pharmacokinetic data.
Petersen PO; Wells TG; Kearns GL
Dev Pharmacol Ther; 1991; 16(4):203-11. PubMed ID: 1782838
[TBL] [Abstract][Full Text] [Related]
17. [Protective effect by piperacillin against renal impairment caused by amikacin].
Kusafuka H; Obayashi T; Iwayama N; Sezaki R; Izuhara Y; Yoshida H; Goto M; Maeda K
Nihon Jinzo Gakkai Shi; 1992 Feb; 34(2):153-62. PubMed ID: 1588766
[TBL] [Abstract][Full Text] [Related]
18. Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity.
Gálvez R; Luengo C; Cornejo R; Kosche J; Romero C; Tobar E; Illanes V; Llanos O; Castro J
Int J Antimicrob Agents; 2011 Aug; 38(2):146-51. PubMed ID: 21612894
[TBL] [Abstract][Full Text] [Related]
19. Interest of therapeutic drug monitoring of aminoglycosides administered by a monodose regimen.
Ben Romdhane H; Ben Fredj N; Chaabane A; Ben Aicha S; Chadly Z; Ben Fadhel N; Boughattas N; Aouam K
Nephrol Ther; 2019 Apr; 15(2):110-114. PubMed ID: 30660586
[TBL] [Abstract][Full Text] [Related]
20. Once-a-day administration of amikacin in neonates: assessment of nephrotoxicity and ototoxicity.
Langhendries JP; Battisti O; Bertrand JM; François A; Darimont J; Ibrahim S; Tulkens PM; Bernard A; Buchet JP; Scalais E
Dev Pharmacol Ther; 1993; 20(3-4):220-30. PubMed ID: 7828457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
